Skip to content
Politically.com Search all
Menu

Final rule 2025-18239

Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur

On May 6, 2024, the Food and Drug Administration (FDA, the Agency, or we) issued a final rule amending the definition of "in vitro diagnostic products" in FDA's regulations. On March 31, 2025, a federal district court vacated that rule. This final rule reverts to the text of the regulation as it existed prior to the effective date of the May 2024 final rule.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2025-18239
Published
Sep 19, 2025
Effective
Sep 19, 2025
Comments close
Not supplied
Federal Register citation
90 FR 45134

Docket identifiers

  • Docket No. FDA-2025-N-1730

CFR references

  • Title 21, part 809